An Overview of the Beat AML® Master Trial: Pioneering Treatment Options and Patient Services
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Recorded on May 10, 2019
Join Dr. Ken Miller as he speaks with Dr. Amy Burd, Vice President of Research and Strategy, and Alissa Gentile, Director of the Clinical Trial Support Center at The Leukemia & Lymphoma Society about LLS’ role in advancing treatment therapies for acute myeloid leukemia (AML). Their discussion focuses on the Beat AML® Master Trial, an innovative clinical trial which matches therapies to patients based on their individual genetic profile, and the role LLS plays in supporting and connecting patients to clinical trials.
 |
 |
| Amy Burd, PhD | Alissa Gentile, MSN, RN |